-
1
-
-
67650469082
-
A review of novel biological tools used in screening for the early detection of lung cancer
-
Ghosal R, Kloer P, Lewis KE. A review of novel biological tools used in screening for the early detection of lung cancer. Postgrad Med J 2009;85:358-363
-
(2009)
Postgrad Med J
, vol.85
, pp. 358-363
-
-
Ghosal, R.1
Kloer, P.2
Lewis, K.E.3
-
3
-
-
23344438114
-
Cochrane systematic reviews of treatments for lung cancer
-
Fong KM, Yang IA, Zimmerman PV, et al. Cochrane systematic reviews of treatments for lung cancer. Respir Med 2005;99:1071-1078
-
(2005)
Respir Med
, vol.99
, pp. 1071-1078
-
-
Fong, K.M.1
Yang, I.A.2
Zimmerman, P.V.3
-
5
-
-
20644459456
-
Novel strategies for the early detection and prevention of lung cancer
-
Wardwell NR, Massion P. Novel strategies for the early detection and prevention of lung cancer. Semin Oncol 2005;32:259-268
-
(2005)
Semin Oncol
, vol.32
, pp. 259-268
-
-
Wardwell, N.R.1
Massion, P.2
-
6
-
-
73349107157
-
Management of lung nodules detected by volume CT scanning
-
van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-2229
-
(2009)
N Engl J Med
, vol.361
, pp. 2221-2229
-
-
Van Klaveren, R.J.1
Oudkerk, M.2
Prokop, M.3
-
7
-
-
33744502855
-
Cancer biomarkers: An invitation to the table
-
Dalton WS, Friend SH. Cancer biomarkers: an invitation to the table. Science 2006;312:1165-1168
-
(2006)
Science
, vol.312
, pp. 1165-1168
-
-
Dalton, W.S.1
Friend, S.H.2
-
8
-
-
59949099451
-
Biomarkers in lung cancer: From early detection to novel therapeutics and decision making
-
Scott A, Salgia R. Biomarkers in lung cancer: from early detection to novel therapeutics and decision making. Biomark Med 2008;2:577-586
-
(2008)
Biomark Med
, vol.2
, pp. 577-586
-
-
Scott, A.1
Salgia, R.2
-
9
-
-
0038299179
-
Charcateristics and prognosis of patients after resection of non-small cell carcinoma measuring 2 cm or less in greatest dimension
-
Okada M, Sakamoto T, Nishio W, et al. Charcateristics and prognosis of patients after resection of non-small cell carcinoma measuring 2 cm or less in greatest dimension. Cancer 2003;98:535-541
-
(2003)
Cancer
, vol.98
, pp. 535-541
-
-
Okada, M.1
Sakamoto, T.2
Nishio, W.3
-
10
-
-
68049083613
-
Clinical significance of carcinoembryonic antigen level for clinical stage i non-small cell lung cancer: Can preoperative carcinoembryonic antigen level predict pathological stage?
-
Kawachi R, Nakazato Y, Takei H, et al. Clinical significance of carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembryonic antigen level predict pathological stage? Interact Cardiovasc Thorac Surg 2009;9:199-202
-
(2009)
Interact Cardiovasc Thorac Surg
, vol.9
, pp. 199-202
-
-
Kawachi, R.1
Nakazato, Y.2
Takei, H.3
-
11
-
-
51049102813
-
Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage i non-small cell lung cancer: External validation of a prognostic score
-
Blankenburg F, Hatz R, Nagel D, et al. Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer: external validation of a prognostic score. Tumour Biol 2008;29:272-277
-
(2008)
Tumour Biol
, vol.29
, pp. 272-277
-
-
Blankenburg, F.1
Hatz, R.2
Nagel, D.3
-
12
-
-
67650760768
-
Serum carcinoembrionic antigen level in non-small-cell lung cancer patients with preoperative normal serum level
-
Tomita M, Shimizu T, Hara M, et al. Serum carcinoembrionic antigen level in non-small-cell lung cancer patients with preoperative normal serum level. Gen Thorac Cardiovasc Surg 2009;57:303-306
-
(2009)
Gen Thorac Cardiovasc Surg
, vol.57
, pp. 303-306
-
-
Tomita, M.1
Shimizu, T.2
Hara, M.3
-
13
-
-
0012277796
-
Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA), and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases
-
Schneider J, Philipp M, Velcovsky HG, et al. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA), and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases. Anticancer Res 2003;23:885-893
-
(2003)
Anticancer Res
, vol.23
, pp. 885-893
-
-
Schneider, J.1
Philipp, M.2
Velcovsky, H.G.3
-
14
-
-
52649178477
-
CYFRA 21.1 in non-small cell lung cancer-standardisation and application during diagnosis
-
Pavićević R, Bubanović G, Franjević A, et al. CYFRA 21.1 in non-small cell lung cancer-standardisation and application during diagnosis. Coll Antropol 2008;32:485-498
-
(2008)
Coll Antropol
, vol.32
, pp. 485-498
-
-
Pavićević, R.1
Bubanović, G.2
Franjević, A.3
-
15
-
-
0043234142
-
Clinical equivalence of two cytokeratin markers in mon-small cell lung cancer: A study of tissue polypeptide antigen, and cytokeratin 19 fragments
-
Buccheri G, Torchio P, Ferrigno D. Clinical equivalence of two cytokeratin markers in mon-small cell lung cancer: a study of tissue polypeptide antigen, and cytokeratin 19 fragments. Chest 2003;124:622-632
-
(2003)
Chest
, vol.124
, pp. 622-632
-
-
Buccheri, G.1
Torchio, P.2
Ferrigno, D.3
-
16
-
-
77953744322
-
Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients
-
Hillas G, Moschos C, Dimakou K, et al. Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients. Scand J Clin Lab Invest 2008;8:1-6
-
(2008)
Scand J Clin Lab Invest
, vol.8
, pp. 1-6
-
-
Hillas, G.1
Moschos, C.2
Dimakou, K.3
-
17
-
-
3042598857
-
Clinical utility of cytokeratins as tumour markers
-
Barak V, Goike H, Panaretakis KW, et al. Clinical utility of cytokeratins as tumour markers. Clin Biochem 2004;37:529-540
-
(2004)
Clin Biochem
, vol.37
, pp. 529-540
-
-
Barak, V.1
Goike, H.2
Panaretakis, K.W.3
-
18
-
-
34249803223
-
Biomarkers for lung cancer: Clinical uses
-
Greenberg AK, Lee MS. Biomarkers for lung cancer: clinical uses. Curr Opin Pulm Med 2007;13:249-255
-
(2007)
Curr Opin Pulm Med
, vol.13
, pp. 249-255
-
-
Greenberg, A.K.1
Lee, M.S.2
-
19
-
-
0043162180
-
Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC)
-
Ferrigno D, Buccheri G, Giordano C. Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC). Lung Cancer 2003;41:311-320
-
(2003)
Lung Cancer
, vol.41
, pp. 311-320
-
-
Ferrigno, D.1
Buccheri, G.2
Giordano, C.3
-
20
-
-
21244486698
-
Pro-gastrin-releasing peptide (proGRP) in patients with benign, and malignant diseases: Comparison with CEA, SCC, CYFRA 21-1, and NSE in patients with lung cancer
-
Molina R, Auge JM, Filella X, et al. Pro-gastrin-releasing peptide (proGRP) in patients with benign, and malignant diseases: comparison with CEA, SCC, CYFRA 21-1, and NSE in patients with lung cancer. Anticancer Res 2005;25:1773-1778
-
(2005)
Anticancer Res
, vol.25
, pp. 1773-1778
-
-
Molina, R.1
Auge, J.M.2
Filella, X.3
-
21
-
-
35348825431
-
The significance of TU M2-PK tumour marker for lung cancer diagnostics
-
Oremek G, Kukshaite R, Sapoutzis N, et al. The significance of TU M2-PK tumour marker for lung cancer diagnostics. Klin Med (Mosk) 2007;85:56-58
-
(2007)
Klin Med (Mosk)
, vol.85
, pp. 56-58
-
-
Oremek, G.1
Kukshaite, R.2
Sapoutzis, N.3
-
22
-
-
0036249158
-
Tumour M2-pyruvate kinase in lung cancer patients: Immunohistochemical detection and disease monitoring
-
Schneider J, Neu K, Grimm H, et al. Tumour M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring. Anticancer Res 2002;22:311-318
-
(2002)
Anticancer Res
, vol.22
, pp. 311-318
-
-
Schneider, J.1
Neu, K.2
Grimm, H.3
-
23
-
-
34247155282
-
C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: The rotterdam study
-
Siemes C, Visser LE, Coebergh JW, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 2006;24:5216-5222
-
(2006)
J Clin Oncol
, vol.24
, pp. 5216-5222
-
-
Siemes, C.1
Visser, L.E.2
Coebergh, J.W.3
-
24
-
-
0345059332
-
Tumour markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors
-
Molina R, Filella X, Augé JM, et al. Tumour markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors. Tumour Biol 2003;24:209-218
-
(2003)
Tumour Biol
, vol.24
, pp. 209-218
-
-
Molina, R.1
Filella, X.2
Augé, J.M.3
-
25
-
-
66449111135
-
Usefulness of serum tumour markers including progastrin-releasing peptide
-
Molina R, Augè JM, Bosch X, et al. Usefulness of serum tumour markers including progastrin-releasing peptide. Tumour Biol 2009;30:121-129
-
(2009)
Tumour Biol
, vol.30
, pp. 121-129
-
-
Molina, R.1
Augè, J.M.2
Bosch, X.3
-
26
-
-
0033162085
-
Tumour markers in lung cancer: EGTM recommendations
-
European Group on Tumour Markers
-
European Group on Tumour Markers. Tumour markers in lung cancer: EGTM recommendations. Anticancer Res 1999;19:2817-2819
-
(1999)
Anticancer Res
, vol.19
, pp. 2817-2819
-
-
-
27
-
-
66649116391
-
The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules
-
Bekci TT, Senol T, Maden E. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules. J Int Med Res 2009;37(2):438-445
-
(2009)
J Int Med Res
, vol.37
, Issue.2
, pp. 438-445
-
-
Bekci, T.T.1
Senol, T.2
Maden, E.3
-
28
-
-
33747074100
-
Immunohistochemical markers of prognosis in non-small cell lung cancer: A review and proposal for a multiphase approach to marker evaluation
-
Zhu CQ, Shih W, Tsao MS. Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 2006;59:790-800
-
(2006)
J Clin Pathol
, vol.59
, pp. 790-800
-
-
Zhu, C.Q.1
Shih, W.2
Tsao, M.S.3
-
29
-
-
34247891719
-
A translational view of the molecular pathogenesis of lung cancer
-
Sato M, Shames DS, Gazdar AF, et al. A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 2007;2:327-343
-
(2007)
J Thorac Oncol
, vol.2
, pp. 327-343
-
-
Sato, M.1
Shames, D.S.2
Gazdar, A.F.3
-
30
-
-
58149134374
-
3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): A potential new tool for early detection of non-small cell lung cancer (NSCLC)
-
Yendamuri S, Vaporciyan AA, Zaidi T, et al. 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung cancer (NSCLC). J Thorac Oncol 2008;3:979-984
-
(2008)
J Thorac Oncol
, vol.3
, pp. 979-984
-
-
Yendamuri, S.1
Vaporciyan, A.A.2
Zaidi, T.3
-
31
-
-
70349388721
-
Understanding prognostic gene expression signatures in lung cancer
-
Zhu CQ, Pintilie M, John T, et al. Understanding prognostic gene expression signatures in lung cancer. Clin Lung Cancer 2009;10:331-340
-
(2009)
Clin Lung Cancer
, vol.10
, pp. 331-340
-
-
Zhu, C.Q.1
Pintilie, M.2
John, T.3
-
32
-
-
33746875641
-
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer
-
Potti A, Mukherjee S, Petersen R, et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-580
-
(2006)
N Engl J Med
, vol.355
, pp. 570-580
-
-
Potti, A.1
Mukherjee, S.2
Petersen, R.3
-
33
-
-
33750966349
-
Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts
-
Hayes DN, Monti S, Parmigiani G, et al. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. J Clin Oncol 2006;24:5079-5090
-
(2006)
J Clin Oncol
, vol.24
, pp. 5079-5090
-
-
Hayes, D.N.1
Monti, S.2
Parmigiani, G.3
-
35
-
-
0035923521
-
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
-
Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001;98:13790-13795
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 13790-13795
-
-
Bhattacharjee, A.1
Richards, W.G.2
Staunton, J.3
-
36
-
-
33847749502
-
Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer
-
Spira A, Beane JE, Shah V, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007;13:361-366
-
(2007)
Nat Med
, vol.13
, pp. 361-366
-
-
Spira, A.1
Beane, J.E.2
Shah, V.3
-
37
-
-
0037226593
-
A molecular signature of metastasis in primary solid tumour
-
Ramaswamy S, Ross KN, Lander ES, et al. A molecular signature of metastasis in primary solid tumour. Nat Genet 2003;33:49-54
-
(2003)
Nat Genet
, vol.33
, pp. 49-54
-
-
Ramaswamy, S.1
Ross, K.N.2
Lander, E.S.3
-
38
-
-
2342419135
-
Expression profiling of non-small cell lung carcinoma identifies metastatic genotypes based on lymphnode tumour burden
-
Hoang CD, D'Cunha J, Tawfic SH, et al. Expression profiling of non-small cell lung carcinoma identifies metastatic genotypes based on lymphnode tumour burden. J Thorac Cardiovasc Surg 2004;127:1332-1342
-
(2004)
J Thorac Cardiovasc Surg
, vol.127
, pp. 1332-1342
-
-
Hoang, C.D.1
D'cunha, J.2
Tawfic, S.H.3
-
39
-
-
18544365698
-
Gene-expression profiles predict survival of patients with lung adenocarcinoma
-
Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002;8:816-824
-
(2002)
Nat Med
, vol.8
, pp. 816-824
-
-
Beer, D.G.1
Kardia, S.L.2
Huang, C.C.3
-
40
-
-
1542608359
-
Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction
-
Endoh H, Tomida S, Yatabe Y, et al. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol 2004;22:811-819
-
(2004)
J Clin Oncol
, vol.22
, pp. 811-819
-
-
Endoh, H.1
Tomida, S.2
Yatabe, Y.3
-
41
-
-
0036606299
-
Molecular profiling of non-small-cell lung cancer and correlation with disease-free survival
-
Wigle DA, Jurisica I, Radulovich N, et al. Molecular profiling of non-small-cell lung cancer and correlation with disease-free survival. Cancer Res 2002;62:3005-3008
-
(2002)
Cancer Res
, vol.62
, pp. 3005-3008
-
-
Wigle, D.A.1
Jurisica, I.2
Radulovich, N.3
-
42
-
-
13244289883
-
Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes
-
Jiang H, Deng Y, Chen HS, et al. Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes. BMC Bioinformatics 2004;5:81
-
(2004)
BMC Bioinformatics
, vol.5
, pp. 81
-
-
Jiang, H.1
Deng, Y.2
Chen, H.S.3
-
43
-
-
2442545413
-
A cross-study comparison of gene expression studies for the molecular classification of lung cancer
-
DOI 10.1158/1078-0432.CCR-03-0490
-
Parmigiani G, Garrett-Mayer ES, Anbazhagan R, et al. A cross-study comparison of gene-expression studies for the molecular classification of lung cancer. Clin Cancer Res 2004;10:2922-2927 (Pubitemid 38619666)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.9
, pp. 2922-2927
-
-
Parmigiani, G.1
Garrett-Mayer, E.S.2
Anbazhagan, R.3
Gabrielson, E.4
-
44
-
-
33845877973
-
A gene expression signature predicts survival of patients with stage i non-small cell lung cancer
-
Lu Y, Lemon W, Liu PY, et al. A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med 2006;3:e467
-
(2006)
PLoS Med
, vol.3
-
-
Lu, Y.1
Lemon, W.2
Liu, P.Y.3
-
45
-
-
33846011470
-
A five-gene signature and clinical outcome in non-small-cell lung cancer
-
Chen HY, Yu SL, Chen CH, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007;356:11-20
-
(2007)
N Engl J Med
, vol.356
, pp. 11-20
-
-
Chen, H.Y.1
Yu, S.L.2
Chen, C.H.3
-
46
-
-
61549143718
-
Clinical impact of high-throughput gene expression studies in lung cancer
-
Beane J, Spira A, Lenburg ME. Clinical impact of high-throughput gene expression studies in lung cancer. J Thorac Oncol 2009;4:109-118
-
(2009)
J Thorac Oncol
, vol.4
, pp. 109-118
-
-
Beane, J.1
Spira, A.2
Lenburg, M.E.3
-
47
-
-
33748491517
-
The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements
-
Shi L, Reil LH, Jones WD, et al. The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006;24:1151-1161
-
(2006)
Nat Biotechnol
, vol.24
, pp. 1151-1161
-
-
Shi, L.1
Reil, L.H.2
Jones, W.D.3
-
48
-
-
18644377457
-
The role of EGF-R expression on patient survival in lung cancer: A systematic review with meta-analysis
-
DOI 10.1183/09031936.02.00296502
-
Meert AP, Martin B, Delmonte P, et al. The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. Eur Respir J 2002;20:975-981 (Pubitemid 35175137)
-
(2002)
European Respiratory Journal
, vol.20
, Issue.4
, pp. 975-981
-
-
Meert, A.-P.1
Martin, B.2
Delmotte, P.3
Berghmans, T.4
Lafitte, J.-J.5
Mascaux, C.6
Paesmans, M.7
Steels, E.8
Verdebout, J.-M.9
Sculier, J.-P.10
-
49
-
-
77349091545
-
Biological and clinical significance of KRAS mutations in lung cancer: An oncogenic driver that contrasts with EGFR mutation
-
Suda K, Tomizawa K, Mitsudomi T. Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation. Cancer Metastasis Rev 2010;29(1):49-60
-
(2010)
Cancer Metastasis Rev
, vol.29
, Issue.1
, pp. 49-60
-
-
Suda, K.1
Tomizawa, K.2
Mitsudomi, T.3
-
50
-
-
59049105640
-
The predictive value of epidermal growth factor receptor tests in patients with pulmonary adenocarcinoma: Review of current 'best evidence' with meta-analysis
-
Gupta R, Dastane AM, McKenna R Jr, et al. The predictive value of epidermal growth factor receptor tests in patients with pulmonary adenocarcinoma: review of current 'best evidence' with meta-analysis. Hum Pathol 2009;40:356-365
-
(2009)
Hum Pathol
, vol.40
, pp. 356-365
-
-
Gupta, R.1
Dastane, A.M.2
McKenna Jr., R.3
-
51
-
-
27244443759
-
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: A Southwest oncology group study
-
Hirsch FR, Varella-Garcia M, McCoy J, et al. Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study. J Clin Oncol 2005;23:6838-6845
-
(2005)
J Clin Oncol
, vol.23
, pp. 6838-6845
-
-
Hirsch, F.R.1
Varella-Garcia, M.2
McCoy, J.3
-
52
-
-
69949162760
-
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
-
Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009;361:947-957
-
(2009)
N Engl J Med
, vol.361
, pp. 947-957
-
-
Mok, T.S.1
Wu, Y.L.2
Thongprasert, S.3
-
53
-
-
17644403128
-
Association of HER-2 overexpression with prognosis in non-small cell lung carcinoma: A metanalysis
-
Nakamura H, Kawasaki N, Taguchi M, et al. Association of HER-2 overexpression with prognosis in non-small cell lung carcinoma: a metanalysis. Cancer 2005;103:1865-1873
-
(2005)
Cancer
, vol.103
, pp. 1865-1873
-
-
Nakamura, H.1
Kawasaki, N.2
Taguchi, M.3
-
54
-
-
0031934761
-
Molecular abnormalities in lung cancer
-
Salgia R, Skarin AT. Molecular abnormalities in lung cancer. J Clin Oncol 1998;16:1207-1217
-
(1998)
J Clin Oncol
, vol.16
, pp. 1207-1217
-
-
Salgia, R.1
Skarin, A.T.2
-
55
-
-
0026654238
-
Ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis
-
Sugio K, Ishida T, Yokoyama H, et al. Ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res 1992;52:2903-2906
-
(1992)
Cancer Res
, vol.52
, pp. 2903-2906
-
-
Sugio, K.1
Ishida, T.2
Yokoyama, H.3
-
56
-
-
0025074419
-
K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung
-
Slebos RJ, Kibbelaar RE, Dalesio O, et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990;323:561-565
-
(1990)
N Engl J Med
, vol.323
, pp. 561-565
-
-
Slebos, R.J.1
Kibbelaar, R.E.2
Dalesio, O.3
-
57
-
-
0032975370
-
Prognostic significance of K-ras codon 12 mutations in patients with resected stage i and II non-small-cell lung cancer
-
Graziano SL, Gamble GP, Newman NB, et al. Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer. J Clin Oncol 1999;17:668-675
-
(1999)
J Clin Oncol
, vol.17
, pp. 668-675
-
-
Graziano, S.L.1
Gamble, G.P.2
Newman, N.B.3
-
58
-
-
65649108558
-
A gene expression signature associated with 'K-ras addiction' reveals regulators of EMT and tumour cell survival
-
Singh A, Greninger P, Rhodes D, et al. A gene expression signature associated with 'K-ras addiction' reveals regulators of EMT and tumour cell survival. Cancer Cell 2009;15:489-500
-
(2009)
Cancer Cell
, vol.15
, pp. 489-500
-
-
Singh, A.1
Greninger, P.2
Rhodes, D.3
-
59
-
-
57349194139
-
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
-
Engelman JA, Chen L, Tan X, et al. Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med 2008;14:1351-1356
-
(2008)
Nat Med
, vol.14
, pp. 1351-1356
-
-
Engelman, J.A.1
Chen, L.2
Tan, X.3
-
60
-
-
70449091786
-
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
-
Barbie DA, Tamayo P, Boehm JS, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009;462:108-112
-
(2009)
Nature
, vol.462
, pp. 108-112
-
-
Barbie, D.A.1
Tamayo, P.2
Boehm, J.S.3
-
61
-
-
77953779015
-
Hepatocyte growth factor is predomintantly expressed by the carcinoma cells in non-small cell lung cancer
-
Tsa MS, Yang Y, Marcus A, et al. Hepatocyte growth factor is predomintantly expressed by the carcinoma cells in non-small cell lung cancer. Hum Pathol 2001;3257-3265
-
(2001)
Hum Pathol
, pp. 3257-3265
-
-
Tsa, M.S.1
Yang, Y.2
Marcus, A.3
-
62
-
-
0031667559
-
Differential expression of Met/ Hepatocyte growth factor receptor in subtypes of non-small cell lung cancer
-
Tsao MS, Liu N, Chen JR, et al. Differential expression of Met/ Hepatocyte growth factor receptor in subtypes of non-small cell lung cancer. Lung Cancer 1998;20:1-16
-
(1998)
Lung Cancer
, vol.20
, pp. 1-16
-
-
Tsao, M.S.1
Liu, N.2
Chen, J.R.3
-
63
-
-
24944468127
-
Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer
-
Cheng TL, Chang MY, Huang SY, et al. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer. Chest 2005;128:1453-1460
-
(2005)
Chest
, vol.128
, pp. 1453-1460
-
-
Cheng, T.L.1
Chang, M.Y.2
Huang, S.Y.3
-
64
-
-
0030043970
-
Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small cell lung cancer
-
Betticher DC, Heighway J, Hasleton PS, et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small cell lung cancer. Br J Cancer 1996;73:294-300
-
(1996)
Br J Cancer
, vol.73
, pp. 294-300
-
-
Betticher, D.C.1
Heighway, J.2
Hasleton, P.S.3
-
65
-
-
0037868819
-
Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival
-
Ratschiller D, Heighway J, Gugger M, et al. Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol 2003;21:2085-2093
-
(2003)
J Clin Oncol
, vol.21
, pp. 2085-2093
-
-
Ratschiller, D.1
Heighway, J.2
Gugger, M.3
-
66
-
-
21844434717
-
Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer
-
Esposito V, Baldi A, De Luca A, et al. Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer. J Clin Pathol 2005;58:734-739
-
(2005)
J Clin Pathol
, vol.58
, pp. 734-739
-
-
Esposito, V.1
Baldi, A.2
De Luca, A.3
-
67
-
-
4544264923
-
Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: A tissue microarray study of 284 cases and 18 markers
-
Au NH, Cheang M, Huntsman DG, et al. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers. J Pathol 2004;204:101-109
-
(2004)
J Pathol
, vol.204
, pp. 101-109
-
-
Au, N.H.1
Cheang, M.2
Huntsman, D.G.3
-
68
-
-
0033843716
-
Expression of cyclin D1, Ki-67 amd PCNA in non-small cell lung cancer: Prognostic significance and comparison with p53 and bcl-2
-
Nguyen VN, Mirejovsky P, Mirejovsky T, et al. Expression of cyclin D1, Ki-67 amd PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2. Acta Histochem 2000;102:323-338
-
(2000)
Acta Histochem
, vol.102
, pp. 323-338
-
-
Nguyen, V.N.1
Mirejovsky, P.2
Mirejovsky, T.3
-
69
-
-
12344255903
-
Ki-67 expression and patients survival in lung cancer: Systematic review of the literature with meta-analysis
-
Martin B, Paesmans M, Mascaux C, et al. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Br J Cancer 2004;91:2108-3025
-
(2004)
Br J Cancer
, vol.91
, pp. 2108-3025
-
-
Martin, B.1
Paesmans, M.2
Mascaux, C.3
-
70
-
-
1542388144
-
Significance of expression of TGF-b in pulmonary metastasis in non-small cell lung cancer tissues
-
Saji H, Nakamura H, Awut I, et al. Significance of expression of TGF-b in pulmonary metastasis in non-small cell lung cancer tissues. Ann Thorac Cardiovasc Surg 2003;92:295-300
-
(2003)
Ann Thorac Cardiovasc Surg
, vol.92
, pp. 295-300
-
-
Saji, H.1
Nakamura, H.2
Awut, I.3
-
71
-
-
0037106265
-
Clinical significance of p21 expression in non-small cell lung cancer
-
Shoji T, Tanaka F, Takata T, et al. Clinical significance of p21 expression in non-small cell lung cancer. J Clin Oncol 2002;20:3865-3871
-
(2002)
J Clin Oncol
, vol.20
, pp. 3865-3871
-
-
Shoji, T.1
Tanaka, F.2
Takata, T.3
-
72
-
-
13844275550
-
Absense of prognostic significance of p21 (WAF1/CIP1) protein expression in non-small cell lung cancer
-
Dworakowska D, Jassem E, Jassem J, et al. Absense of prognostic significance of p21 (WAF1/CIP1) protein expression in non-small cell lung cancer. Acta oncol 2005;44:75-79
-
(2005)
Acta Oncol
, vol.44
, pp. 75-79
-
-
Dworakowska, D.1
Jassem, E.2
Jassem, J.3
-
73
-
-
0034848442
-
Reduced expression of cell-cycle regulator p27(Kip1) correlates with a shortened survival in non-small cell lung cancer
-
Tsukamoto S, Sugio K, Sakada T, et al. Reduced expression of cell-cycle regulator p27(Kip1) correlates with a shortened survival in non-small cell lung cancer. Lung Cancer 2001;34:83-90
-
(2001)
Lung Cancer
, vol.34
, pp. 83-90
-
-
Tsukamoto, S.1
Sugio, K.2
Sakada, T.3
-
74
-
-
14444268041
-
Prognostic role of the cicli-dependent kinase inhibitor p27 in non-small cell lung lung cancer
-
Esposito V, Baldi A, De Luca A, et al. Prognostic role of the cicli-dependent kinase inhibitor p27 in non-small cell lung lung cancer. Cancer Res 1997;57:3381-3385
-
(1997)
Cancer Res
, vol.57
, pp. 3381-3385
-
-
Esposito, V.1
Baldi, A.2
De Luca, A.3
-
75
-
-
9144243525
-
Analysis of cell cycle regulator proteins in non-small cell lung cancer
-
Esposito V, Baldi A, Tonini G, et al. Analysis of cell cycle regulator proteins in non-small cell lung cancer. J Clin Pathol 2004;57:58-63
-
(2004)
J Clin Pathol
, vol.57
, pp. 58-63
-
-
Esposito, V.1
Baldi, A.2
Tonini, G.3
-
76
-
-
0037307872
-
Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer
-
Cheng YL, Lee SC, Harn HJ, et al. Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer. Eur J Cardiothoracic Surg 2003;23:221-228
-
(2003)
Eur J Cardiothoracic Surg
, vol.23
, pp. 221-228
-
-
Cheng, Y.L.1
Lee, S.C.2
Harn, H.J.3
-
77
-
-
0030989021
-
Altered retino blastoma protein expression in nonsmall cell lung cancer: Its synergistic effects with altered ras and p53 protein status on prognosis
-
Dosaka-Akita H, Hu SX, Fujino M, et al. Altered retino blastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Cancer 1997;79:1329-1337
-
(1997)
Cancer
, vol.79
, pp. 1329-1337
-
-
Dosaka-Akita, H.1
Hu, S.X.2
Fujino, M.3
-
78
-
-
19944427869
-
Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma
-
Burke L, Flieder DB, Guinee DG, et al. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Clin Cancer Res 2005;11:232-241
-
(2005)
Clin Cancer Res
, vol.11
, pp. 232-241
-
-
Burke, L.1
Flieder, D.B.2
Guinee, D.G.3
-
79
-
-
0035144783
-
Loss of p16 and/or pRb protein expression in NSCLC. An immunohistochemical and prognostic study
-
Chen JT, Chen YC, Chen CY, et al. Loss of p16 and/or pRb protein expression in NSCLC. An immunohistochemical and prognostic study. Lung Cancer 2001;31:163-170
-
(2001)
Lung Cancer
, vol.31
, pp. 163-170
-
-
Chen, J.T.1
Chen, Y.C.2
Chen, C.Y.3
-
80
-
-
0031841384
-
IARC database of p53 gene mutations in human tumours and cell lines: Updated compilation, revised formats and new visualisation tools
-
Hainaut P, Hernandez T, Robinson A, et al. IARC database of p53 gene mutations in human tumours and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res 1998;26:205-213
-
(1998)
Nucleic Acids Res
, vol.26
, pp. 205-213
-
-
Hainaut, P.1
Hernandez, T.2
Robinson, A.3
-
81
-
-
0024452546
-
P53: A frequent target for genetic abnormalities in lung cancer
-
Takahashi T, Nau MM, Chiba I, et al. p53: a frequent target for genetic abnormalities in lung cancer. Science 1989;246:491-494
-
(1989)
Science
, vol.246
, pp. 491-494
-
-
Takahashi, T.1
Nau, M.M.2
Chiba, I.3
-
82
-
-
20444374483
-
Circulating tumour-derived DNA and RNA markers in blood: A tool for early detection, diagnostics, and follow-up?
-
Bremnes RM, Sirera R, Camps C. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? Lung Cancer 2005;49:1-12
-
(2005)
Lung Cancer
, vol.49
, pp. 1-12
-
-
Bremnes, R.M.1
Sirera, R.2
Camps, C.3
-
83
-
-
0345687975
-
Detecting lung cancer in plasma with the use of multiple genetic markers
-
Andriani F, Conte D, Mastrangelo T, et al. Detecting lung cancer in plasma with the use of multiple genetic markers. Int J Cancer 2004;108:91-96
-
(2004)
Int J Cancer
, vol.108
, pp. 91-96
-
-
Andriani, F.1
Conte, D.2
Mastrangelo, T.3
-
84
-
-
0042964835
-
P53 mutations and survival in stage i non-small-cell lung cancer: Results of a prospective study
-
Ahrendt SA, Hu Y, Buta M, et al. p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study. J Natl Cancer Inst 2003;95:961-970
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 961-970
-
-
Ahrendt, S.A.1
Hu, Y.2
Buta, M.3
-
85
-
-
10744230829
-
MDM2 gene amplification: A new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC)
-
Dworakowska D, Jassem E, Jassem J, et al. MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC). Lung Cancer 2004;43:285-295
-
(2004)
Lung Cancer
, vol.43
, pp. 285-295
-
-
Dworakowska, D.1
Jassem, E.2
Jassem, J.3
-
86
-
-
0041343301
-
Role of Bcl-2 as a prognostic factor for survival in lung cancer: A systematic review of the literature with meta-analysis
-
DOI 10.1038/sj.bjc.6601095
-
Martin B, Paesmans M, Berghmans T, et al. Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 2003;89:55-64 (Pubitemid 36897935)
-
(2003)
British Journal of Cancer
, vol.89
, Issue.1
, pp. 55-64
-
-
Martin, B.1
Paesmans, M.2
Berghmans, T.3
Branle, F.4
Ghisdal, L.5
Mascaux, C.6
Meert, A.-P.7
Steels, E.8
Vallot, F.9
Verdebout, J.-M.10
Lafitte, J.-J.11
Sculier, J.-P.12
-
87
-
-
0842286954
-
Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-XL in resected non-small cell lung cancers
-
Groeger AM, Esposito V, De Luca A, et al. Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-XL in resected non-small cell lung cancers. Histopathology 2004;44:54-63
-
(2004)
Histopathology
, vol.44
, pp. 54-63
-
-
Groeger, A.M.1
Esposito, V.2
De Luca, A.3
-
88
-
-
0035985813
-
Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers
-
Hanaoka T, Nakayama J, Haniuda M, et al. Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers. Int J Clin Oncol 2002;7:152-158
-
(2002)
Int J Clin Oncol
, vol.7
, pp. 152-158
-
-
Hanaoka, T.1
Nakayama, J.2
Haniuda, M.3
-
89
-
-
18044373030
-
Clinical application of biological markers for treatments of resectable non-small-cell lung cancer
-
Huang C, Liu D, Masuya D, et al. Clinical application of biological markers for treatments of resectable non-small-cell lung cancer. Br J Cancer 2005;92:1231-1239
-
(2005)
Br J Cancer
, vol.92
, pp. 1231-1239
-
-
Huang, C.1
Liu, D.2
Masuya, D.3
-
90
-
-
4544250024
-
Gene-promoter hypermethylation as a biomarker in lung cancer
-
Belinsky SA. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 2004;4:707-717
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 707-717
-
-
Belinsky, S.A.1
-
91
-
-
0037068329
-
DNA methylation analysis: A powerful new tool for lung cancer diagnosis
-
Tsou JA, Hagen JA, Carpenter CL, et al. DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 2002;21:5450-5461
-
(2002)
Oncogene
, vol.21
, pp. 5450-5461
-
-
Tsou, J.A.1
Hagen, J.A.2
Carpenter, C.L.3
-
92
-
-
0035132145
-
Aberrant promoter methylation of multiple genes in nonsmall cell lung cancers
-
Zochbauer-Muller S, Fong KM, Virmani AK, et al. Aberrant promoter methylation of multiple genes in nonsmall cell lung cancers. Cancer Res 2001;61:249-255
-
(2001)
Cancer Res
, vol.61
, pp. 249-255
-
-
Zochbauer-Muller, S.1
Fong, K.M.2
Virmani, A.K.3
-
93
-
-
0033607147
-
In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis
-
Nuovo GJ, Plaia TW, Belinsky SA, et al. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci USA 1999;96:12754-12759
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 12754-12759
-
-
Nuovo, G.J.1
Plaia, T.W.2
Belinsky, S.A.3
-
94
-
-
33645521023
-
Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort
-
Belinsky SA, Liechty KC, Gentry FD, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006;66:3338-3344
-
(2006)
Cancer Res
, vol.66
, pp. 3338-3344
-
-
Belinsky, S.A.1
Liechty, K.C.2
Gentry, F.D.3
-
95
-
-
35648953334
-
Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma
-
Han-Shui Hsu MD, Tsz-Pei Chen MS, Chein-Hui Hung MS, et al. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Cancer 2007;110:2019-2026
-
(2007)
Cancer
, vol.110
, pp. 2019-2026
-
-
Han-Shui Hsu, M.D.1
Tsz-Pei Chen, M.S.2
Chein-Hui Hung, M.S.3
-
96
-
-
32044438696
-
Aberrant DNA methylation of E-Cadherin and p16 genes in rat lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine
-
DOI 10.1002/mc.20162
-
Kato A, Shimizu K, Shimoichi Y, et al. Aberrant DNA methylation of E-cadherin and p16 genes in rat lung adenocarcinomas induced by Nnitrosobis( 2-hydroxypropyl)amine. Mol Carcinog 2006;45:106-111 (Pubitemid 43202583)
-
(2006)
Molecular Carcinogenesis
, vol.45
, Issue.2
, pp. 106-111
-
-
Kato, A.1
Shimizu, K.2
Shimoichi, Y.3
Fujii, H.4
Honoki, K.5
Tsujiuchi, T.6
-
97
-
-
0042563143
-
Promoter hypermethylation of tumour suppressor and tumour-related genes in non-small cell lung cancers
-
Yanagawa N, Tamura G, Oizumi H, et al. Promoter hypermethylation of tumour suppressor and tumour-related genes in non-small cell lung cancers. Cancer Sci 2003;94:589-592
-
(2003)
Cancer Sci
, vol.94
, pp. 589-592
-
-
Yanagawa, N.1
Tamura, G.2
Oizumi, H.3
-
98
-
-
12244297095
-
Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: Associations with clinical outcome
-
Brabender J, Usadel H, Metzger R, et al. Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome. Clin Cancer Res 2003;9:223-227
-
(2003)
Clin Cancer Res
, vol.9
, pp. 223-227
-
-
Brabender, J.1
Usadel, H.2
Metzger, R.3
-
99
-
-
24644502624
-
Methylation discriminators in NSCLC identified by a microarray based approach
-
Field JK, Liloglou T, Warrak S, et al. Methylation discriminators in NSCLC identified by a microarray based approach. Int J Oncol 2005;27:105-111
-
(2005)
Int J Oncol
, vol.27
, pp. 105-111
-
-
Field, J.K.1
Liloglou, T.2
Warrak, S.3
-
100
-
-
33947629246
-
Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer
-
Brena RM, Morrison C, Liyanarachchi S, et al. Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer. PLoS Med 2007;4:e108
-
(2007)
PLoS Med
, vol.4
-
-
Brena, R.M.1
Morrison, C.2
Liyanarachchi, S.3
-
101
-
-
0033577058
-
Molecular detection of tumour cells in bronchoalveolar lavage fluid from patients with early stage lung cancer
-
Ahrendt SA, Chow JT, Xu LH, et al. Molecular detection of tumour cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 1999;91:332-339
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 332-339
-
-
Ahrendt, S.A.1
Chow, J.T.2
Xu, L.H.3
-
102
-
-
67649399383
-
Potential uses of microRNA in lung cancer diagnosis, prognosis and therapy
-
Wang QZ, Xu W, Habib N. Potential uses of microRNA in lung cancer diagnosis, prognosis and therapy. Curr Cancer Drug Target 2009;9:572-594
-
(2009)
Curr Cancer Drug Target
, vol.9
, pp. 572-594
-
-
Wang, Q.Z.1
Xu, W.2
Habib, N.3
-
103
-
-
12144290519
-
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
-
Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci 2004;101:2999-3004
-
(2004)
Proc Natl Acad Sci
, vol.101
, pp. 2999-3004
-
-
Calin, G.A.1
Sevignani, C.2
Dumitru, C.D.3
-
104
-
-
33144490646
-
A microRNA expression signature of human solid tumours defines cancer gene targets
-
Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumours defines cancer gene targets. Proc Natl Acad Sci USA 2006;103:2257-2261
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 2257-2261
-
-
Volinia, S.1
Calin, G.A.2
Liu, C.G.3
-
105
-
-
33750370444
-
MicroRNA signatures in human cancers
-
Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-866
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 857-866
-
-
Calin, G.A.1
Croce, C.M.2
-
106
-
-
40249092910
-
MicroRNA- 21 targets tumour suppressor genes in invasion and metastasis
-
Zhu S, Wu H, Wu F, et al. MicroRNA- 21 targets tumour suppressor genes in invasion and metastasis. Cell Res 2008;18:350-359
-
(2008)
Cell Res
, vol.18
, pp. 350-359
-
-
Zhu, S.1
Wu, H.2
Wu, F.3
-
107
-
-
48749122914
-
Circulating microRNAs as stable blood-based markers for cancer detection
-
Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513-10518
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 10513-10518
-
-
Mitchell, P.S.1
Parkin, R.K.2
Kroh, E.M.3
-
108
-
-
42449098100
-
Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues
-
Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 2008;14:844-852
-
(2008)
RNA
, vol.14
, pp. 844-852
-
-
Peltier, H.J.1
Latham, G.J.2
-
109
-
-
61449208911
-
Downregulation of microRNA expression in the lungs of rat exposed to cigarette smoke
-
Izzotti A, Calin GA, Arri P, et al. Downregulation of microRNA expression in the lungs of rat exposed to cigarette smoke. FASEB J 2009;23:806-812
-
(2009)
FASEB J
, vol.23
, pp. 806-812
-
-
Izzotti, A.1
Calin, G.A.2
Arri, P.3
-
110
-
-
33644819964
-
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
-
Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9(3):189-198
-
(2006)
Cancer Cell
, vol.9
, Issue.3
, pp. 189-198
-
-
Yanaihara, N.1
Caplen, N.2
Bowman, E.3
-
111
-
-
65349166324
-
Diagnostic assay based on has-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma
-
Lebanony D, Benjamin H, Gilad S, et al. Diagnostic assay based on has-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 2009;27:2030-2037
-
(2009)
J Clin Oncol
, vol.27
, pp. 2030-2037
-
-
Lebanony, D.1
Benjamin, H.2
Gilad, S.3
-
112
-
-
37349096992
-
MicroRNA signature predicts survival and relapse in lung cancer
-
Yu SL, Chen HY, Chang GC, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008;13:48-57
-
(2008)
Cancer Cell
, vol.13
, pp. 48-57
-
-
Yu, S.L.1
Chen, H.Y.2
Chang, G.C.3
-
113
-
-
35748956868
-
Let-7 MicroRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis
-
Inamura K, Togashi Y, Nomura K, et al. Let-7 MicroRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. Lung Cancer 2007;58:392-396
-
(2007)
Lung Cancer
, vol.58
, pp. 392-396
-
-
Inamura, K.1
Togashi, Y.2
Nomura, K.3
-
114
-
-
20044395613
-
RAS is regulated by the let-7 MicroRNA family
-
Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 MicroRNA family. Cell 2005;120:635-647
-
(2005)
Cell
, vol.120
, pp. 635-647
-
-
Johnson, S.M.1
Grosshans, H.2
Shingara, J.3
-
115
-
-
2542626605
-
Reduced expression of the let-7 MicroRNAs in human lung cancers in association with shortened postoperative survival
-
Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 MicroRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004;64:3753-3756
-
(2004)
Cancer Res
, vol.64
, pp. 3753-3756
-
-
Takamizawa, J.1
Konishi, H.2
Yanagisawa, K.3
-
116
-
-
34447632218
-
Role of dicer and Drosha for endothelial microRNA expression and angiogenesis
-
Kuehbacher A, Urbich C, Zeiher AM, et al. Role of dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007;101:59-68
-
(2007)
Circ Res
, vol.101
, pp. 59-68
-
-
Kuehbacher, A.1
Urbich, C.2
Zeiher, A.M.3
-
117
-
-
55549127406
-
Let-7 regulates DICER expression and constitutes a negative feedback loop
-
Tokumaru S, Suzuki M, Yamada H, et al. Let-7 regulates DICER expression and constitutes a negative feedback loop. Carcinogenesis 2008;29:2073-2077
-
(2008)
Carcinogenesis
, vol.29
, pp. 2073-2077
-
-
Tokumaru, S.1
Suzuki, M.2
Yamada, H.3
-
118
-
-
27544495514
-
A polycistronic microRNA cluster, miR 17-92 is overexpressed in human lung cancers and enhances cell proliferation
-
Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronic microRNA cluster, miR 17-92 is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005;65:9628-9632
-
(2005)
Cancer Res
, vol.65
, pp. 9628-9632
-
-
Hayashita, Y.1
Osada, H.2
Tatematsu, Y.3
-
119
-
-
33846188098
-
MicroRNAs as oncogenes and tumour suppressors
-
Zhang B, Pan X, Cobb GP, et al. MicroRNAs as oncogenes and tumour suppressors. Dev Biol 2007;302:1-12
-
(2007)
Dev Biol
, vol.302
, pp. 1-12
-
-
Zhang, B.1
Pan, X.2
Cobb, G.P.3
-
120
-
-
33749507943
-
A Small piece in the cancer puzzle: MicroRNAs as tumour suppressors and oncogenes
-
Kent OA, Mendell JT. A Small piece in the cancer puzzle: microRNAs as tumour suppressors and oncogenes. Oncogene 2006;25:6188-6196
-
(2006)
Oncogene
, vol.25
, pp. 6188-6196
-
-
Kent, O.A.1
Mendell, J.T.2
-
121
-
-
59649093464
-
Evolution of microRNAs expression during human bronchial squamous carcinogenesis
-
Mascaux C, Laes JF, Anthoine G, et al. Evolution of microRNAs expression during human bronchial squamous carcinogenesis. Eur Respir J 2009;32:352-359
-
(2009)
Eur Respir J
, vol.32
, pp. 352-359
-
-
Mascaux, C.1
Laes, J.F.2
Anthoine, G.3
-
122
-
-
33847107236
-
DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer
-
Zheng Z, Chen T, Li X, et al. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. N Engl J Med 2007;356:800-808
-
(2007)
N Engl J Med
, vol.356
, pp. 800-808
-
-
Zheng, Z.1
Chen, T.2
Li, X.3
-
123
-
-
33748435058
-
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
-
Olaussen KA, Dunant A, Fouret P, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006;355:983-991
-
(2006)
N Engl J Med
, vol.355
, pp. 983-991
-
-
Olaussen, K.A.1
Dunant, A.2
Fouret, P.3
-
124
-
-
34447573875
-
Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: A phase III trial in non-small-cell lung cancer
-
Cobo M, Isla D, Massuti B, et al. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer. J Clin Oncol 2007;25:2747-2754
-
(2007)
J Clin Oncol
, vol.25
, pp. 2747-2754
-
-
Cobo, M.1
Isla, D.2
Massuti, B.3
-
125
-
-
0029821872
-
Microsatellite alterations in plasma DNA of small cell lung cancer patients
-
DOI 10.1038/nm0996-1033
-
Chen XQ, Stroun M, Magnenat JL, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996;2:1033-1035 (Pubitemid 26306844)
-
(1996)
Nature Medicine
, vol.2
, Issue.9
, pp. 1033-1035
-
-
Chen, X.Q.1
Stroun, M.2
Magnenat, J.-L.3
Nicod, L.P.4
Kurt, A.-M.5
Lyautey, J.6
Lederrey, C.7
Anker, P.8
-
126
-
-
0033590626
-
Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma
-
Wistuba II, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999;18:643-650
-
(1999)
Oncogene
, vol.18
, pp. 643-650
-
-
Wistuba, I.I.1
Behrens, C.2
Milchgrub, S.3
-
127
-
-
0034282535
-
Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering
-
Girard L, Zochbauer-Müller S, Virmani AK, et al. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 2000;60:4894-4906
-
(2000)
Cancer Res
, vol.60
, pp. 4894-4906
-
-
Girard, L.1
Zochbauer-Müller, S.2
Virmani, A.K.3
-
128
-
-
25444439612
-
Genome-wide loss of heterozygosity and its clinical associations in non small cell lung cancer
-
Tseng RC, Chang JW, Hsien FJ, et al. Genome-wide loss of heterozygosity and its clinical associations in non small cell lung cancer. Int J Cancer 2005;117:241-247
-
(2005)
Int J Cancer
, vol.117
, pp. 241-247
-
-
Tseng, R.C.1
Chang, J.W.2
Hsien, F.J.3
-
129
-
-
19244370711
-
High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints
-
Wistuba I, Behrens C, Virmani AK, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 2000;60:1949-1960
-
(2000)
Cancer Res
, vol.60
, pp. 1949-1960
-
-
Wistuba, I.1
Behrens, C.2
Virmani, A.K.3
-
130
-
-
33644877818
-
BJ-TSA-9, a novel human tumour-specific gene, has potential as a biomarker of lung cancer
-
Li Y, Dong X, Yin Y, et al. BJ-TSA-9, a novel human tumour-specific gene, has potential as a biomarker of lung cancer. Neoplasia 2005;7:1073-1080
-
(2005)
Neoplasia
, vol.7
, pp. 1073-1080
-
-
Li, Y.1
Dong, X.2
Yin, Y.3
-
131
-
-
0035865985
-
Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-smallcell lung cancer
-
Iwao K, Watanabe T, Fujiwara Y, et al. Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-smallcell lung cancer. Int J Cancer 2001;91(4):433-437
-
(2001)
Int J Cancer
, vol.91
, Issue.4
, pp. 433-437
-
-
Iwao, K.1
Watanabe, T.2
Fujiwara, Y.3
-
132
-
-
70349189541
-
Genomic and proteomic biomarkers for cancer: A multitude of opportunities
-
Tainsky MA. Genomic and proteomic biomarkers for cancer: a multitude of opportunities. Biochim Biophys Acta 2009;1796:176-193
-
(2009)
Biochim Biophys Acta
, vol.1796
, pp. 176-193
-
-
Tainsky, M.A.1
-
133
-
-
0016168626
-
Two-dimensional acrylamide gel electrophoresis of cancer-patient serum proteins
-
Wright GL Jr. Two-dimensional acrylamide gel electrophoresis of cancer-patient serum proteins. Ann Clin Lab Sci 1974;4:281-293
-
(1974)
Ann Clin Lab Sci
, vol.4
, pp. 281-293
-
-
Wright Jr., G.L.1
-
134
-
-
0036468595
-
Two-dimensional gel electrophoresis: Recent advances in sample preparation, detection and quantitation
-
Lilley KS, Rassaq A, Dupree P. Two-dimensional gel electrophoresis: recent advances in sample preparation, detection and quantitation. Curr Opin Chem Biol 2002;6:46-50
-
(2002)
Curr Opin Chem Biol
, vol.6
, pp. 46-50
-
-
Lilley, K.S.1
Rassaq, A.2
Dupree, P.3
-
135
-
-
0028804205
-
Lung tumour cells: A multivariate approach to cell classification using two-dimensional protein pattern
-
Schmid HR, Schmitter D, Blum P, et al. Lung tumour cells: a multivariate approach to cell classification using two-dimensional protein pattern. Electrophoresis 1995;16:1961-1968
-
(1995)
Electrophoresis
, vol.16
, pp. 1961-1968
-
-
Schmid, H.R.1
Schmitter, D.2
Blum, P.3
-
136
-
-
0035992398
-
Proteomic analysis of lung adenocarcinoma: Identification of a highly expressed set of proteins in tumours
-
Chen G, Gharib TG, Huang CC, et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumours. Clin Cancer Res 2002;8:2298-2305
-
(2002)
Clin Cancer Res
, vol.8
, pp. 2298-2305
-
-
Chen, G.1
Gharib, T.G.2
Huang, C.C.3
-
137
-
-
0040746269
-
A database of protein expression in lung cancer
-
Oh JM, Brichory F, Puravs E, et al. A database of protein expression in lung cancer. Proteomics 2001;1:1303-1319
-
(2001)
Proteomics
, vol.1
, pp. 1303-1319
-
-
Oh, J.M.1
Brichory, F.2
Puravs, E.3
-
138
-
-
2942529235
-
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy
-
Oh P, Li Y, Yu J, et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 2004;429:629-635
-
(2004)
Nature
, vol.429
, pp. 629-635
-
-
Oh, P.1
Li, Y.2
Yu, J.3
-
139
-
-
0343376097
-
Difference gel electrophoresis: A single gel method for detecting changes in protein extracts
-
Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997;18:2071-2077
-
(1997)
Electrophoresis
, vol.18
, pp. 2071-2077
-
-
Unlu, M.1
Morgan, M.E.2
Minden, J.S.3
-
140
-
-
34547572949
-
Is proteomics the new genomics?
-
Cox J, Mann M. Is proteomics the new genomics? Cell 2007;130:395-398
-
(2007)
Cell
, vol.130
, pp. 395-398
-
-
Cox, J.1
Mann, M.2
-
141
-
-
0041735992
-
Proteomic patterns of tumour subsets in non-small-cell lung cancer
-
Yanagisawa K, Shyr Y, Xu BJ, et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003;362:433-439
-
(2003)
Lancet
, vol.362
, pp. 433-439
-
-
Yanagisawa, K.1
Shyr, Y.2
Xu, B.J.3
-
142
-
-
34247170626
-
Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of nonsmall cell lung cancer
-
Huang LJ, Chen SX, Huang Y, et al. Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of nonsmall cell lung cancer. Lung Cancer 2006;54:87-94
-
(2006)
Lung Cancer
, vol.54
, pp. 87-94
-
-
Huang, L.J.1
Chen, S.X.2
Huang, Y.3
-
143
-
-
1242339545
-
Proteomic analysis of lung biopsies. differential protein expression profile between peritumoural and tumoural tissue
-
Alfonso P, Catala M, Rico-Morales ML, et al. Proteomic analysis of lung biopsies. differential protein expression profile between peritumoural and tumoural tissue. Proteomics 2004;4:442-447
-
(2004)
Proteomics
, vol.4
, pp. 442-447
-
-
Alfonso, P.1
Catala, M.2
Rico-Morales, M.L.3
-
144
-
-
0037683738
-
Discovery of distinct protein profiles specific for lung tumours and pre-malignant lung lesions by SELDI mass spectrometry
-
Zhukov TA, Johanson RA, Cantor AB, et al. Discovery of distinct protein profiles specific for lung tumours and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer 2003;40:267-279
-
(2003)
Lung Cancer
, vol.40
, pp. 267-279
-
-
Zhukov, T.A.1
Johanson, R.A.2
Cantor, A.B.3
-
145
-
-
2542640080
-
Mass spectrometry as a diagnostic and a cancer biomarker discovery tool:Opportunities and potential
-
Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential. Mol Cell Proteomics 2004;3(4):367-378
-
(2004)
Mol Cell Proteomics
, vol.3
, Issue.4
, pp. 367-378
-
-
Diamandis, E.P.1
-
146
-
-
33750456480
-
Reverse phase protein array: Validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
-
Tibes R, Qiu Y, Lu Y, et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol Cancer Ther 2006;5:2512-2521
-
(2006)
Mol Cancer Ther
, vol.5
, pp. 2512-2521
-
-
Tibes, R.1
Qiu, Y.2
Lu, Y.3
-
147
-
-
13444280261
-
Protein microarrays as tools for functional proteomics
-
LaBaer J, Ramachandran N. Protein microarrays as tools for functional proteomics. Curr Opin Chem Biol 2005;9:14-19
-
(2005)
Curr Opin Chem Biol
, vol.9
, pp. 14-19
-
-
Labaer, J.1
Ramachandran, N.2
-
148
-
-
39749121336
-
Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response
-
Madoz-Gurpide J, Kuick R, Wang H, et al. Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Mol Cell Proteomics 2007;7:268-281
-
(2007)
Mol Cell Proteomics
, vol.7
, pp. 268-281
-
-
Madoz-Gurpide, J.1
Kuick, R.2
Wang, H.3
-
149
-
-
74049115774
-
Mass spectrometry-based label free quantitative proteomics
-
[Epub ahead of print]
-
Zhu W, Smith JW, Huang CM. Mass spectrometry-based label free quantitative proteomics. J Biomed Biotechnol 2010;2010:840518. [Epub ahead of print]
-
(2010)
J Biomed Biotechnol
, vol.2010
, pp. 840518
-
-
Zhu, W.1
Smith, J.W.2
Huang, C.M.3
-
150
-
-
34249310279
-
Proteomic approaches for serum biomarker discovery in cancer
-
Maurya P, Meleady P, Dowling P, et al. Proteomic approaches for serum biomarker discovery in cancer. Anticancer Res 2007;27:1247-1255
-
(2007)
Anticancer Res
, vol.27
, pp. 1247-1255
-
-
Maurya, P.1
Meleady, P.2
Dowling, P.3
-
151
-
-
0036399228
-
Shotgun proteomics and biomarker discovery
-
McDonald WH, Yates JR III. Shotgun proteomics and biomarker discovery. Dis Markers 2002;18:99-105
-
(2002)
Dis Markers
, vol.18
, pp. 99-105
-
-
McDonald, W.H.1
Yates III, J.R.2
-
152
-
-
31644438577
-
Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MUDPIT)
-
Chen EI, Hewel J, Felding-Habermann B, et al. Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MUDPIT). Mol Cell Proteomics 2006;5:53-56
-
(2006)
Mol Cell Proteomics
, vol.5
, pp. 53-56
-
-
Chen, E.I.1
Hewel, J.2
Felding-Habermann, B.3
-
153
-
-
16344369038
-
Clinical-scale high-throughput human plasma proteome analysis: Lung adenocarcinoma
-
Fujii K, Nakano T, Kanazawa M, et al. Clinical-scale high-throughput human plasma proteome analysis: lung adenocarcinoma. Proteomics 2005;5:1150-1159
-
(2005)
Proteomics
, vol.5
, pp. 1150-1159
-
-
Fujii, K.1
Nakano, T.2
Kanazawa, M.3
-
154
-
-
65449150181
-
MRM screening/ biomarker discovery with linear ion trap MS: A library of human cancer-specific peptides
-
Yang X, Lazar IM. MRM screening/ biomarker discovery with linear ion trap MS: a library of human cancer-specific peptides. BMC Cancer 2009;9:96
-
(2009)
BMC Cancer
, vol.9
, pp. 96
-
-
Yang, X.1
Lazar, I.M.2
-
156
-
-
33645721632
-
Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins
-
Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 2006;5:573-588
-
(2006)
Mol Cell Proteomics
, vol.5
, pp. 573-588
-
-
Anderson, L.1
Hunter, C.L.2
-
157
-
-
38349068918
-
Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry, and stable isotope dilution
-
Keshishian H, Addona T, Burgess M, et al. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry, and stable isotope dilution. Mol Cell Proteomics 2007;6:2212-2229
-
(2007)
Mol Cell Proteomics
, vol.6
, pp. 2212-2229
-
-
Keshishian, H.1
Addona, T.2
Burgess, M.3
-
158
-
-
0036849944
-
The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer
-
Inoshima N, Nakanishi Y, Minami T, et al. The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer. Clin Cancer Res 2002;8:3480-3486
-
(2002)
Clin Cancer Res
, vol.8
, pp. 3480-3486
-
-
Inoshima, N.1
Nakanishi, Y.2
Minami, T.3
-
159
-
-
14844286511
-
Vascular endothelial growth factor expression in pN2 on-small cell lung cancer: Lack of prognostic value
-
Tomita M, Matsuzaki Y, Shimizu T, et al. Vascular endothelial growth factor expression in pN2 on-small cell lung cancer: lack of prognostic value. Respirology 2005;10:31-35
-
(2005)
Respirology
, vol.10
, pp. 31-35
-
-
Tomita, M.1
Matsuzaki, Y.2
Shimizu, T.3
-
160
-
-
0038010147
-
Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines
-
Lantuejoul S, Constantin B, Drabkin H, et al. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines. J Pathol 2003;200:336-347
-
(2003)
J Pathol
, vol.200
, pp. 336-347
-
-
Lantuejoul, S.1
Constantin, B.2
Drabkin, H.3
-
161
-
-
67649971550
-
Connective Tissue-Activating Peptide III (CTAP III): A novel blood biomarker for early lung cancer detection
-
Yee J, Sadar M, Sin Don D, et al. Connective Tissue-Activating Peptide III (CTAP III): a novel blood biomarker for early lung cancer detection. J Clin Oncol 2009;17:2787-2792
-
(2009)
J Clin Oncol
, vol.17
, pp. 2787-2792
-
-
Yee, J.1
Sadar, M.2
Sin Don, D.3
-
162
-
-
0037314662
-
Up-regulation of tumour interleukin-8 expression by infiltrating macrophages: Its correlation with tumour angiogenesis and patient survival in non-small cell lung cancer
-
Chen JJ, Yao PL, Yuan A, et al. Up-regulation of tumour interleukin-8 expression by infiltrating macrophages: its correlation with tumour angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res 2003;9:729-737
-
(2003)
Clin Cancer Res
, vol.9
, pp. 729-737
-
-
Chen, J.J.1
Yao, P.L.2
Yuan, A.3
-
163
-
-
17744406409
-
Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer
-
Arenberg DA, Keane MP, DiGiovine B, et al. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest 1998;102:465-472
-
(1998)
J Clin Invest
, vol.102
, pp. 465-472
-
-
Arenberg, D.A.1
Keane, M.P.2
Digiovine, B.3
-
164
-
-
0036469157
-
Increased expression of b-cateninpredicts better prognosis in nonsmall cell lung carcinomas
-
Hommura F, Furuuchi K, Yamazaki K, et al. Increased expression of b-cateninpredicts better prognosis in nonsmall cell lung carcinomas. Cancer 2002;94:752-758
-
(2002)
Cancer
, vol.94
, pp. 752-758
-
-
Hommura, F.1
Furuuchi, K.2
Yamazaki, K.3
-
165
-
-
0036521335
-
The significance of E-cadherin and a-, b-, and c-catenin expression in surgically treated non-small cell lung cancers of 3 cm or less in size
-
Lee YC, Wu CT, Chen CS, et al. The significance of E-cadherin and a-, b-, and c-catenin expression in surgically treated non-small cell lung cancers of 3 cm or less in size. J Thorac Cardiovasc Surg 2002;123:502-507
-
(2002)
J Thorac Cardiovasc Surg
, vol.123
, pp. 502-507
-
-
Lee, Y.C.1
Wu, C.T.2
Chen, C.S.3
-
166
-
-
77953738985
-
Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance
-
Kase S, Sugio K, Yamazaki K, et al. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res 2000;64:789-796
-
(2000)
Clin Cancer Res
, vol.64
, pp. 789-796
-
-
Kase, S.1
Sugio, K.2
Yamazaki, K.3
-
167
-
-
0042762970
-
Prognostic significance of E-cadherin and b-catenin in resected stage i non-small Paci, Rapicetta & Maramotti cell lung cancer
-
Choi YS, Shim YM, Kim SH, et al. Prognostic significance of E-cadherin and b-catenin in resected stage I non-small Paci, Rapicetta & Maramotti cell lung cancer. Eur J Cardio Thorac Surg 2003;24:441-449
-
(2003)
Eur J Cardio Thorac Surg
, vol.24
, pp. 441-449
-
-
Choi, Y.S.1
Shim, Y.M.2
Kim, S.H.3
-
168
-
-
0035105335
-
E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer
-
Liu D, Huang CL, Kameyama K, et al. E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann Thorac Surg 2001;71:949-955
-
(2001)
Ann Thorac Surg
, vol.71
, pp. 949-955
-
-
Liu, D.1
Huang, C.L.2
Kameyama, K.3
-
169
-
-
0033760493
-
Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer
-
Passlick B, Sienel W, Seen-Hibler R, et al. Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin Cancer Res 2000;6:3944-3948
-
(2000)
Clin Cancer Res
, vol.6
, pp. 3944-3948
-
-
Passlick, B.1
Sienel, W.2
Seen-Hibler, R.3
-
170
-
-
5144220875
-
Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumour cells, is a significant prognostic factor in non-small-cell lung cancer
-
Ishikawa S, Takenaka K, Yanagihara K, et al. Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumour cells, is a significant prognostic factor in non-small-cell lung cancer. Clin Cancer Res 2004;10:6579-6585
-
(2004)
Clin Cancer Res
, vol.10
, pp. 6579-6585
-
-
Ishikawa, S.1
Takenaka, K.2
Yanagihara, K.3
-
171
-
-
69249154583
-
Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer
-
Takano A, Ishikawa N, Nishino R, et al. Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer. Cancer Res 2009;69:6694-6703
-
(2009)
Cancer Res
, vol.69
, pp. 6694-6703
-
-
Takano, A.1
Ishikawa, N.2
Nishino, R.3
-
172
-
-
11144356221
-
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours
-
Lantuejoul S, Soria JC, Moro-Sibilot D, et al. Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours. Br J Cancer 2004;90:1222-1229
-
(2004)
Br J Cancer
, vol.90
, pp. 1222-1229
-
-
Lantuejoul, S.1
Soria, J.C.2
Moro-Sibilot, D.3
-
173
-
-
34147220127
-
Serum amyloid A protein: A potential biomarker correlated with clinical stage of lung cancer
-
Liu DH, Wang XM, Zhang LJ, et al. Serum amyloid A protein: a potential biomarker correlated with clinical stage of lung cancer. Biomed Environ Sci 2007;20:33-40
-
(2007)
Biomed Environ Sci
, vol.20
, pp. 33-40
-
-
Liu, D.H.1
Wang, X.M.2
Zhang, L.J.3
-
174
-
-
0035866794
-
Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer
-
Hsu NY, Ho HC, Chow KC, et al. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res 2001;61:2727-2731
-
(2001)
Cancer Res
, vol.61
, pp. 2727-2731
-
-
Hsu, N.Y.1
Ho, H.C.2
Chow, K.C.3
-
175
-
-
37049026705
-
Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography, and LC-MS/MS
-
Heo SH, Lee SJ, Ryoo HM, et al. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography, and LC-MS/MS. Proteomics 2007;7:4292-4302
-
(2007)
Proteomics
, vol.7
, pp. 4292-4302
-
-
Heo, S.H.1
Lee, S.J.2
Ryoo, H.M.3
-
176
-
-
70350323631
-
Diagnosis value of serum B7-H3 expression in non-small cell lung cancer
-
Zhang G, Xu Y, Lu X, et al. Diagnosis value of serum B7-H3 expression in non-small cell lung cancer. Lung Cancer 2009;66:245-249
-
(2009)
Lung Cancer
, vol.66
, pp. 245-249
-
-
Zhang, G.1
Xu, Y.2
Lu, X.3
-
177
-
-
0023637473
-
Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung
-
Addis BJ, Hamid Q, Ibrahim NB, et al. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung. J Pathol 1987;153:137-150
-
(1987)
J Pathol
, vol.153
, pp. 137-150
-
-
Addis, B.J.1
Hamid, Q.2
Ibrahim, N.B.3
-
178
-
-
0035503380
-
Proteomics-based identification of protein gene product 9.5 as a tumour antigen that induces a humoral immune response in lung cancer
-
Brichory F, Beer D, Le Naour F, et al. Proteomics-based identification of protein gene product 9.5 as a tumour antigen that induces a humoral immune response in lung cancer. Cancer Res 2001;61:7908-7912
-
(2001)
Cancer Res
, vol.61
, pp. 7908-7912
-
-
Brichory, F.1
Beer, D.2
Le Naour, F.3
-
179
-
-
3042816190
-
Hypoxia-indicible factor-1a in non small cell lung cancer: Relation to growth factor, protease and apoptosis pathways
-
Swinson DEB, Jones JL, Cox G, et al. Hypoxia-indicible factor-1a in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer 2004;111:43-50
-
(2004)
Int J Cancer
, vol.111
, pp. 43-50
-
-
Deb, S.1
Jones, J.L.2
Cox, G.3
-
180
-
-
4644304354
-
Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small cell lung cancer
-
Toledo G, Sola JJ, Lozano MD, et al. Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small cell lung cancer. Mod Pathol 2004;17:440-448
-
(2004)
Mod Pathol
, vol.17
, pp. 440-448
-
-
Toledo, G.1
Sola, J.J.2
Lozano, M.D.3
-
181
-
-
23044494636
-
Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients
-
Maciel CM, Junqueira M, Paschoal ME, et al. Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients. J Exp Ther Oncol 2005;5:31-38
-
(2005)
J Exp Ther Oncol
, vol.5
, pp. 31-38
-
-
MacIel, C.M.1
Junqueira, M.2
Paschoal, M.E.3
-
182
-
-
0037649051
-
HnRNP B1 expression in benign and malignant lung disease
-
Snead DR, Perunovic B, Cullen N, et al. hnRNP B1 expression in benign and malignant lung disease. J Pathol 2003;200:88-94
-
(2003)
J Pathol
, vol.200
, pp. 88-94
-
-
Snead, D.R.1
Perunovic, B.2
Cullen, N.3
-
184
-
-
23944522808
-
The sentinel within: Exploiting the immune system for cancer biomarkers
-
Anderson KS, LaBaer J. The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res 2005;4:1123-1133
-
(2005)
J Proteome Res
, vol.4
, pp. 1123-1133
-
-
Anderson, K.S.1
Labaer, J.2
-
185
-
-
0037227993
-
Harnessing immunity for cancer marker discovery
-
Hanash S. Harnessing immunity for cancer marker discovery. Nat Biotechnol 2003;21:37-38
-
(2003)
Nat Biotechnol
, vol.21
, pp. 37-38
-
-
Hanash, S.1
-
186
-
-
0034113998
-
P53 antibodies in the sera of patients with various types of cancer: A review
-
Soussi T. P53 antibodies in the sera of patients with various types of cancer: a review. Cancer Res 2000;60:1777-1788
-
(2000)
Cancer Res
, vol.60
, pp. 1777-1788
-
-
Soussi, T.1
-
187
-
-
41149178259
-
Autoantibodies to tumour-associated antigens: Reporters from the immune system
-
Tan EM, Zhang J. Autoantibodies to tumour-associated antigens: reporters from the immune system. Immunol Rev 2008;222:328-340
-
(2008)
Immunol Rev
, vol.222
, pp. 328-340
-
-
Tan, E.M.1
Zhang, J.2
-
188
-
-
33750315127
-
Profiling tumour-associated antibodies for early detection of non-small cell lung cancer
-
Zhong L, Coe SP, Stromberg AJ, et al. Profiling tumour-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 2006;1:513-519
-
(2006)
J Thorac Oncol
, vol.1
, pp. 513-519
-
-
Zhong, L.1
Coe, S.P.2
Stromberg, A.J.3
-
189
-
-
37549061448
-
Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer
-
Pereira-Faca SR, Kuick R, Puravs E, et al. Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer. Cancer Res 2007;67:12000-12006
-
(2007)
Cancer Res
, vol.67
, pp. 12000-12006
-
-
Pereira-Faca, S.R.1
Kuick, R.2
Puravs, E.3
-
190
-
-
40649124272
-
Autoantibodies in lung cancer: Possibilities for early detection and subsequent cure
-
Chapman CJ, Murray A, McElveen JE, et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 2008;63:228-233
-
(2008)
Thorax
, vol.63
, pp. 228-233
-
-
Chapman, C.J.1
Murray, A.2
McElveen, J.E.3
-
191
-
-
33646098665
-
Humoral immune responses of lung cancer patients against tumour antigen NY-ESO-1
-
Tureci O, Mack U, Luxemburger U, et al. Humoral immune responses of lung cancer patients against tumour antigen NY-ESO-1. Cancer Lett 2006;236:64-71
-
(2006)
Cancer Lett
, vol.236
, pp. 64-71
-
-
Tureci, O.1
MacK, U.2
Luxemburger, U.3
-
192
-
-
35348931537
-
Targeting the neural cell adhesion molecule in cancer
-
Jensen M, Berthold F. Targeting the neural cell adhesion molecule in cancer. Cancer Lett 2007;258:9-21
-
(2007)
Cancer Lett
, vol.258
, pp. 9-21
-
-
Jensen, M.1
Berthold, F.2
-
194
-
-
11344272281
-
The promise of metabolomics in cancer molecular therapeutics
-
Fan TW, Lane AN, Higashi RM. The promise of metabolomics in cancer molecular therapeutics. Curr Opin Mol Ther 2004;6:584-592
-
(2004)
Curr Opin Mol Ther
, vol.6
, pp. 584-592
-
-
Fan, T.W.1
Lane, A.N.2
Higashi, R.M.3
-
195
-
-
30844471152
-
Characterization of the biochemical effects of 1 nitronaphthalene in rats using global metabolic profiling by NMR spectroscopy and pattern recognition
-
Azmi J, Connelly J, Holmes E, et al. Characterization of the biochemical effects of 1 nitronaphthalene in rats using global metabolic profiling by NMR spectroscopy and pattern recognition. Biomarkers 2005;10:401-416
-
(2005)
Biomarkers
, vol.10
, pp. 401-416
-
-
Azmi, J.1
Connelly, J.2
Holmes, E.3
-
196
-
-
68549085318
-
Altered regulation of metabolic pathways in human lung cancer discerned by (13) C stable isotope-resolved metabolomics (SIRM)
-
Fan TW, Lane AN, Higashi RM, et al. Altered regulation of metabolic pathways in human lung cancer discerned by (13) C stable isotope-resolved metabolomics (SIRM). Mol Cancer 2009;8:41
-
(2009)
Mol Cancer
, vol.8
, pp. 41
-
-
Fan, T.W.1
Lane, A.N.2
Higashi, R.M.3
-
197
-
-
2942737264
-
Tumour-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer
-
Kim H, Kwon YM, Kim JS, et al. Tumour-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol 2004;22:2363-2370
-
(2004)
J Clin Oncol
, vol.22
, pp. 2363-2370
-
-
Kim, H.1
Kwon, Y.M.2
Kim, J.S.3
-
198
-
-
4143132121
-
Promoter hypermethylation of resected bronchial margins: A field defect of changes?
-
Guo M, House MG, Hooker C, et al. Promoter hypermethylation of resected bronchial margins: a field defect of changes? Clin Cancer Res 2004;10:5131-5136
-
(2004)
Clin Cancer Res
, vol.10
, pp. 5131-5136
-
-
Guo, M.1
House, M.G.2
Hooker, C.3
-
199
-
-
26444431818
-
Promoter methylation of genes in bronchial lavages: A marker for early diagnosis of primary and relapsing non-small cell lung cancer?
-
De Fraipont F, Moro-Sibilot D, Michelland S, et al. Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer? Lung Cancer 2005;50:199-209
-
(2005)
Lung Cancer
, vol.50
, pp. 199-209
-
-
De Fraipont, F.1
Moro-Sibilot, D.2
Michelland, S.3
-
200
-
-
33645967485
-
Methylation of RAS association domain family protein 1A as a biomarker of lung cancer
-
Grote HJ, Schmiemann V, Geddert H, et al. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer. Cancer 2006;108:129-134
-
(2006)
Cancer
, vol.108
, pp. 129-134
-
-
Grote, H.J.1
Schmiemann, V.2
Geddert, H.3
-
201
-
-
27744434546
-
Methylation assay for the diagnosis of lung cancer on bronchial aspirates: A cohort study
-
Schmiemann V, Bocking A, Kazimirek M, et al. Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort study. Clin Cancer Res 2005;11:7728-7734
-
(2005)
Clin Cancer Res
, vol.11
, pp. 7728-7734
-
-
Schmiemann, V.1
Bocking, A.2
Kazimirek, M.3
-
202
-
-
0035866349
-
Cancer-specific genomic instability in bronchial lavage: A molecular tool for lung cancer detection
-
Liloglou T, Maloney P, Xinarianos G, et al. Cancer-specific genomic instability in bronchial lavage: a molecular tool for lung cancer detection. Cancer Res 2001;61:1624-1628
-
(2001)
Cancer Res
, vol.61
, pp. 1624-1628
-
-
Liloglou, T.1
Maloney, P.2
Xinarianos, G.3
-
203
-
-
15244351454
-
Quantification of free RNA in serum and bronchial lavage: A new diagnostic tool in lung cancer detection?
-
Schmidt B, Engel E, Carstensen T, et al. Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection? Lung Cancer 2005;48:145-147
-
(2005)
Lung Cancer
, vol.48
, pp. 145-147
-
-
Schmidt, B.1
Engel, E.2
Carstensen, T.3
-
204
-
-
0034326238
-
Predicting lung cancer by detecting aberrant promoter methylation in sputum
-
Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000;60:5954-5958
-
(2000)
Cancer Res
, vol.60
, pp. 5954-5958
-
-
Palmisano, W.A.1
Divine, K.K.2
Saccomanno, G.3
-
205
-
-
33846869304
-
Genetic deletions in sputum as diagnostic markers for early detection of stage i non-small cell lung cancer
-
Li R, Todd NW, Qiu Q, et al. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res 2007;13:482-487
-
(2007)
Clin Cancer Res
, vol.13
, pp. 482-487
-
-
Li, R.1
Todd, N.W.2
Qiu, Q.3
-
206
-
-
25144439378
-
Assessing abnormal gene promoter methylation in paraffin-embedded sputum from patients with NSCLC
-
Olaussen KA, Soria JC, Park YW, et al. Assessing abnormal gene promoter methylation in paraffin-embedded sputum from patients with NSCLC. Eur J Cancer 2005;41:2112-2119
-
(2005)
Eur J Cancer
, vol.41
, pp. 2112-2119
-
-
Olaussen, K.A.1
Soria, J.C.2
Park, Y.W.3
-
207
-
-
0037096424
-
Increase of sensitivity of sputum cytology using high-resolution image cytometry: Field study results
-
Palcic B, Garner DM, Beveridge J, et al. Increase of sensitivity of sputum cytology using high-resolution image cytometry: field study results. Cytometry 2002;50:168-176
-
(2002)
Cytometry
, vol.50
, pp. 168-176
-
-
Palcic, B.1
Garner, D.M.2
Beveridge, J.3
-
208
-
-
33751322125
-
Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer
-
Kettunen E, Salmenkivi K, Vuopala K, et al. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer. Lung Cancer 2006;54:169-176
-
(2006)
Lung Cancer
, vol.54
, pp. 169-176
-
-
Kettunen, E.1
Salmenkivi, K.2
Vuopala, K.3
-
209
-
-
37349048532
-
Proteomics as a method for early detection of cancer: A review of proteomics, exhaled breath condensate, and lung cancer screening
-
Conrad DH, Goyette J, Thomas PS. Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening. J Gen Intern Med 2008;23:78-84
-
(2008)
J Gen Intern Med
, vol.23
, pp. 78-84
-
-
Conrad, D.H.1
Goyette, J.2
Thomas, P.S.3
-
210
-
-
0036968928
-
Exhaled breath condensate: An evolving tool for noninvasive evaluation of lung disease
-
Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol 2002;110:28-34
-
(2002)
J Allergy Clin Immunol
, vol.110
, pp. 28-34
-
-
Hunt, J.1
-
211
-
-
3042582133
-
Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer
-
Carpagnano GE, Foschino-Barbaro MP, Resta O, et al. Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer. Oncology 2004;66:180-184
-
(2004)
Oncology
, vol.66
, pp. 180-184
-
-
Carpagnano, G.E.1
Foschino-Barbaro, M.P.2
Resta, O.3
-
212
-
-
24944519230
-
3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer
-
Carpagnano GE, Foschino-Barbaro MP, Mule G, et al. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer. Am J Respir Crit Care Med 2005;172:738-744
-
(2005)
Am J Respir Crit Care Med
, vol.172
, pp. 738-744
-
-
Carpagnano, G.E.1
Foschino-Barbaro, M.P.2
Mule, G.3
-
213
-
-
67349256184
-
Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients
-
Carpagnano GE, Spanevello A, Carpagnano F, et al. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients. Lung Cancer 2009;64(3):334-340
-
(2009)
Lung Cancer
, vol.64
, Issue.3
, pp. 334-340
-
-
Carpagnano, G.E.1
Spanevello, A.2
Carpagnano, F.3
-
214
-
-
34548687010
-
IL-2, TNF-alpha, and leptin: Local versus systemic concentrations in NSCLC patients
-
Carpagnano GE, Spanevello A, Curci C, et al. IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients. Oncol Res 2007;16(8):375-381
-
(2007)
Oncol Res
, vol.16
, Issue.8
, pp. 375-381
-
-
Carpagnano, G.E.1
Spanevello, A.2
Curci, C.3
-
215
-
-
0022191230
-
Volatile organic compounds in exhaled air from patients with lung cancer
-
Gordon SM, Szidon JP, Krotoszynski BK, et al. Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem 1985;31:1278-1282
-
(1985)
Clin Chem
, vol.31
, pp. 1278-1282
-
-
Gordon, S.M.1
Szidon, J.P.2
Krotoszynski, B.K.3
-
216
-
-
34447298617
-
Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array
-
Mazzone PJ, Hammel J, Dweik R, et al. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax 2007;62:565-568
-
(2007)
Thorax
, vol.62
, pp. 565-568
-
-
Mazzone, P.J.1
Hammel, J.2
Dweik, R.3
-
217
-
-
2942754069
-
Increased keratin content detected by protomi analysis of exhaled breath condensate from healthy persons who smoke
-
Gianazza E, Allegra L, Bucchioni E, et al. Increased keratin content detected by protomi analysis of exhaled breath condensate from healthy persons who smoke. Am J Med 2004;117(1):51-54
-
(2004)
Am J Med
, vol.117
, Issue.1
, pp. 51-54
-
-
Gianazza, E.1
Allegra, L.2
Bucchioni, E.3
-
218
-
-
61449150588
-
Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer
-
Paci M, Maramotti S, Bellesia E, et al. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. Lung Cancer 2009;64:92-97
-
(2009)
Lung Cancer
, vol.64
, pp. 92-97
-
-
Paci, M.1
Maramotti, S.2
Bellesia, E.3
-
220
-
-
0642311916
-
Quantification of free circulating DNA as a diagnostic marker in lung cancer
-
Sozzi G, Conte D, Leon M, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003;21:3902-3908
-
(2003)
J Clin Oncol
, vol.21
, pp. 3902-3908
-
-
Sozzi, G.1
Conte, D.2
Leon, M.3
-
221
-
-
33748046788
-
Quantitative detection of p53 mutations in plasma DNA from tobacco smokers
-
Hagiwara N, Mechanic LE, Trivers GE, et al. Quantitative detection of p53 mutations in plasma DNA from tobacco smokers. Cancer Res 2006;66:8309-8317
-
(2006)
Cancer Res
, vol.66
, pp. 8309-8317
-
-
Hagiwara, N.1
Mechanic, L.E.2
Trivers, G.E.3
-
222
-
-
0032696782
-
Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: A prospect for early diagnosis
-
Sozzi G, Musso K, Ratcliffe C, et al. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis. Clin Cancer Res 1999;5:2689-2692
-
(1999)
Clin Cancer Res
, vol.5
, pp. 2689-2692
-
-
Sozzi, G.1
Musso, K.2
Ratcliffe, C.3
-
223
-
-
35648953334
-
Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma
-
Hsu HS, Chen TP, Hung CH, et al. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Cancer 2007;110:2019-2026
-
(2007)
Cancer
, vol.110
, pp. 2019-2026
-
-
Hsu, H.S.1
Chen, T.P.2
Hung, C.H.3
-
224
-
-
34247217491
-
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum
-
Belinsky SA, Grimes MJ, Casas E, et al. Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. Br J Cancer 2007;96:1278-1283
-
(2007)
Br J Cancer
, vol.96
, pp. 1278-1283
-
-
Belinsky, S.A.1
Grimes, M.J.2
Casas, E.3
-
225
-
-
0034750642
-
Circulating RNA as tumour marker: Detection of 5T4 mRNA in breast and lung cancer patient serum
-
Kopreski MS, Benko FA, Gocke CD. Circulating RNA as tumour marker: detection of 5T4 mRNA in breast and lung cancer patient serum. Ann NY Acad Sci 2001;945:172-178
-
(2001)
Ann NY Acad Sci
, vol.945
, pp. 172-178
-
-
Kopreski, M.S.1
Benko, F.A.2
Gocke, C.D.3
-
226
-
-
67650520139
-
Detection of cancer with serum miRNAs on an oligonucleotide microarray
-
Lodes MJ, Caraballo M, Suciu D, et al. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One 2009;4(7):e6229
-
(2009)
PLoS One
, vol.4
, Issue.7
-
-
Lodes, M.J.1
Caraballo, M.2
Suciu, D.3
-
227
-
-
53349177819
-
Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases
-
Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006
-
(2008)
Cell Res
, vol.18
, pp. 997-1006
-
-
Chen, X.1
Ba, Y.2
Ma, L.3
-
229
-
-
33750727368
-
Genomic signatures to guide the use of chemotherapeutics
-
Potti A, Dressman HK, Bild A, et al. Genomic signatures to guide the use of chemotherapeutics. Nat Med 2006;12:1294-1300
-
(2006)
Nat Med
, vol.12
, pp. 1294-1300
-
-
Potti, A.1
Dressman, H.K.2
Bild, A.3
-
230
-
-
35348860753
-
Pharmacogenomics strategies provide rational approach to the treatment of cisplatin-resistant patients with advanced cancer
-
Hsu DS, Balakumaran BS, Acharya CR, et al. Pharmacogenomics strategies provide rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol 2007;25:4350-4357
-
(2007)
J Clin Oncol
, vol.25
, pp. 4350-4357
-
-
Hsu, D.S.1
Balakumaran, B.S.2
Acharya, C.R.3
-
231
-
-
33747028745
-
Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database
-
Gemma A, Li C, Sugiyama Y, et al. Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database. BMC Cancer 2006;6:174
-
(2006)
BMC Cancer
, vol.6
, pp. 174
-
-
Gemma, A.1
Li, C.2
Sugiyama, Y.3
-
232
-
-
70349376330
-
Molecular predictive and prognostic markers in non-small-cell lung cancer
-
Coate LE, John T, Tsao MS, et al. Molecular predictive and prognostic markers in non-small-cell lung cancer. Lancet Oncol 2009;10:1001-1010
-
(2009)
Lancet Oncol
, vol.10
, pp. 1001-1010
-
-
Coate, L.E.1
John, T.2
Tsao, M.S.3
-
233
-
-
60849109966
-
Standard operating procedures for serum and plasma collection: Early detection research network consensus statement standard operating procedure integration working group
-
Tuck MK, Chan DW, Chia D, et al. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res 2009;8:113-117
-
(2009)
J Proteome Res
, vol.8
, pp. 113-117
-
-
Tuck, M.K.1
Chan, D.W.2
Chia, D.3
-
234
-
-
0038012549
-
Biological sample collection and processing for molecular epidemiological studies
-
Holland NT, Smith MT, Eskenazi B, et al. Biological sample collection and processing for molecular epidemiological studies. Mutat Res 2003;543:217-234
-
(2003)
Mutat Res
, vol.543
, pp. 217-234
-
-
Holland, N.T.1
Smith, M.T.2
Eskenazi, B.3
-
236
-
-
77953788200
-
-
(National Cancer Institute, Division of Cancer Prevention) Available from:
-
Early Detection Research Network (National Cancer Institute, Division of Cancer Prevention). Available from: http://www.cancer.gov/edrn
-
Early Detection Research Network
-
-
-
237
-
-
0035908491
-
Phases of biomarker development for early detection of cancer
-
Sullivan Pepe M, Etzioni R, Feng Z, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001;93:1054-1061
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 1054-1061
-
-
Sullivan Pepe, M.1
Etzioni, R.2
Feng, Z.3
-
238
-
-
23644432019
-
Statistics subcommittee of the NCI-EORT working group on cancer diagnostics
-
McShane LM, Altman DG, Sauerbrei W, et al. Statistics subcommittee of the NCI-EORT working group on cancer diagnostics. Eur J Cancer 2005;41(12):1690- 1696
-
(2005)
Eur J Cancer
, vol.41
, Issue.12
, pp. 1690-1696
-
-
McShane, L.M.1
Altman, D.G.2
Sauerbrei, W.3
-
239
-
-
0034750609
-
Detection of amplifiable messenger RNA in the serum of patients with lung cancer
-
Fleischhacker M, Beinert T, Ermitsch M, et al. Detection of amplifiable messenger RNA in the serum of patients with lung cancer. Ann NY Acad Sci 2001;945:179-188
-
(2001)
Ann NY Acad Sci
, vol.945
, pp. 179-188
-
-
Fleischhacker, M.1
Beinert, T.2
Ermitsch, M.3
-
240
-
-
15044356588
-
Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction
-
Sueoka E, Sueoka N, Iwanaga K, et al. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction. Lung Cancer 2005;48(1):77-83
-
(2005)
Lung Cancer
, vol.48
, Issue.1
, pp. 77-83
-
-
Sueoka, E.1
Sueoka, N.2
Iwanaga, K.3
-
241
-
-
0036898622
-
P16(INK4A) hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer
-
Bearzatto A, Conte D, Frattini M, et al. p16(INK4A) hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Clin Cancer Res 2002;8(12):3782-3787
-
(2002)
Clin Cancer Res
, vol.8
, Issue.12
, pp. 3782-3787
-
-
Bearzatto, A.1
Conte, D.2
Frattini, M.3
-
242
-
-
0037114362
-
Detection of p16 hypermethylation in circulating plasma DNA of non-small-cell lung cancer patients
-
An Q, Liu Y, Gao Y, et al. Detection of p16 hypermethylation in circulating plasma DNA of non-small-cell lung cancer patients. Cancer Lett 2002;188:109-114
-
(2002)
Cancer Lett
, vol.188
, pp. 109-114
-
-
An, Q.1
Liu, Y.2
Gao, Y.3
-
243
-
-
0346888541
-
Hypermethylation of p16INK4alpha in Chinese lung cancer patients: Biological and clinical implications
-
Liu Y, An Q, Li L, et al. Hypermethylation of p16INK4alpha in Chinese lung cancer patients: biological and clinical implications. Carcinogenesis 2003;24:1897-1901
-
(2003)
Carcinogenesis
, vol.24
, pp. 1897-1901
-
-
Liu, Y.1
An, Q.2
Li, L.3
-
244
-
-
0033788509
-
Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: Follow-up study and prognostic significance
-
Gonzalez R, Silva JM, Sanchez A, et al. Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance. Ann Oncol 2000;11:1097-1104
-
(2000)
Ann Oncol
, vol.11
, pp. 1097-1104
-
-
Gonzalez, R.1
Silva, J.M.2
Sanchez, A.3
-
245
-
-
0345687975
-
Detecting lung cancer in plasma with the use of multiple genetic markers
-
Andriani F, Conte D, Mastrangelo T, et al. Detecting lung cancer in plasma with the use of multiple genetic markers. Int J Cancer 2004;108(1):91-96
-
(2004)
Int J Cancer
, vol.108
, Issue.1
, pp. 91-96
-
-
Andriani, F.1
Conte, D.2
Mastrangelo, T.3
-
246
-
-
77953764319
-
Methylation patterns and K-ras mutations in tumour and paired serum of resected non-small-cell lung cancer patients
-
Ramirez JL, Sarries C, de Castro PL, et al. Methylation patterns and K-ras mutations in tumour and paired serum of resected non-small-cell lung cancer patients. Cancer Lett 2003;11:1219-1225
-
(2003)
Cancer Lett
, vol.11
, pp. 1219-1225
-
-
Ramirez, J.L.1
Sarries, C.2
De Castro, P.L.3
-
247
-
-
0037081085
-
Quantitative adenomatous polyposis coli promoter methylation analysis in tumour tissue, serum and plasma DNA of patients with lung cancer
-
Usadel H, Brabender J, Danenberg KD, et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumour tissue, serum and plasma DNA of patients with lung cancer. Cancer Res 2002;62:371-375
-
(2002)
Cancer Res
, vol.62
, pp. 371-375
-
-
Usadel, H.1
Brabender, J.2
Danenberg, K.D.3
-
248
-
-
0034528340
-
Detection of microsatellite instability and loss of heterozygosity in serum DNA of small and non-small cell lung cancer patients: A tool for early diagnosis?
-
Cuda G, Gallelli A, Nistico A, et al. Detection of microsatellite instability and loss of heterozygosity in serum DNA of small and non-small cell lung cancer patients: a tool for early diagnosis? Lung Cancer 2000;30:211-214
-
(2000)
Lung Cancer
, vol.30
, pp. 211-214
-
-
Cuda, G.1
Gallelli, A.2
Nistico, A.3
-
249
-
-
0034102472
-
Detection of microsatellite alterations in DNA isolated in from tumour cells and from plasma DNA of patients with lung cancer
-
Bruhn N, Beinert T, Oehm C, et al. Detection of microsatellite alterations in DNA isolated in from tumour cells and from plasma DNA of patients with lung cancer. Ann NY Acad Sci 2000;906:72-82
-
(2000)
Ann NY Acad Sci
, vol.906
, pp. 72-82
-
-
Bruhn, N.1
Beinert, T.2
Oehm, C.3
-
250
-
-
2942525078
-
Genetic abnormalities in plasma DNA of patients with lung cancer and other respiratory diseases
-
Kahn S, Coulson JM, Woll PJ. Genetic abnormalities in plasma DNA of patients with lung cancer and other respiratory diseases. Int J Cancer 2004;110:891-895
-
(2004)
Int J Cancer
, vol.110
, pp. 891-895
-
-
Kahn, S.1
Coulson, J.M.2
Woll, P.J.3
-
251
-
-
0038326550
-
Plasma DNA microsatellite panels as sensitive and tumour-specific marker in lung cancer patients
-
Beau-Faller M, Gaub MP, Schneider A, et al. Plasma DNA microsatellite panels as sensitive and tumour-specific marker in lung cancer patients. Int J Cancer 2003;105:361-370
-
(2003)
Int J Cancer
, vol.105
, pp. 361-370
-
-
Beau-Faller, M.1
Gaub, M.P.2
Schneider, A.3
-
252
-
-
2442593569
-
Improved diagnostic sensitivity for lung cancer using an automated quantitative cytology system and uridine 5¢-triphosphate-induced sputum specimens
-
Johnson FL, Turic B, Kemp R, et al. Improved diagnostic sensitivity for lung cancer using an automated quantitative cytology system and uridine 5¢-triphosphate-induced sputum specimens. Chest 2004;125:157S-8S
-
(2004)
Chest
, vol.125
-
-
Johnson, F.L.1
Turic, B.2
Kemp, R.3
-
253
-
-
0031427367
-
Prospective detection of preclinical lung cancer: Results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression
-
Tockman MS, Mulshine JL, Piantadosi S, et al. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res 1997;3:2237-2246
-
(1997)
Clin Cancer Res
, vol.3
, pp. 2237-2246
-
-
Tockman, M.S.1
Mulshine, J.L.2
Piantadosi, S.3
-
254
-
-
0037174792
-
A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens
-
Sokolowa IA, Bubendorf L, O'Hare A, et al. A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens. Cancer 2002;96:306-315
-
(2002)
Cancer
, vol.96
, pp. 306-315
-
-
Sokolowa, I.A.1
Bubendorf, L.2
O'hare, A.3
-
255
-
-
0033396697
-
Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: A clinical marker of early lung cancer detection
-
Fielding P, Turnbull L, Prime W, et al. Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection. Clin Cancer Res 1999;5:4048-4052
-
(1999)
Clin Cancer Res
, vol.5
, pp. 4048-4052
-
-
Fielding, P.1
Turnbull, L.2
Prime, W.3
-
256
-
-
1642493715
-
Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients
-
Gessner C, Kuhn H, Toepfer K, et al. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients. Lung Cancer 2004;43:215-222
-
(2004)
Lung Cancer
, vol.43
, pp. 215-222
-
-
Gessner, C.1
Kuhn, H.2
Toepfer, K.3
-
257
-
-
15844372318
-
ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer
-
Simon GR, Sharma S, Cantor A, et al. ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer. Chest 2005;127:978-983
-
(2005)
Chest
, vol.127
, pp. 978-983
-
-
Simon, G.R.1
Sharma, S.2
Cantor, A.3
-
258
-
-
42549088992
-
BRCA1: A novel prognostic factor in resected non-small-cell lung cancer
-
Rosell R, Shrzypski M, Jassem E, et al. BRCA1: a novel prognostic factor in resected non-small-cell lung cancer. PLoS ONE 2007;2:e1129
-
(2007)
PLoS ONE
, vol.2
-
-
Rosell, R.1
Shrzypski, M.2
Jassem, E.3
-
259
-
-
36849041454
-
Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non-small cell lung cancer
-
Tsao MS, Aviel-Ronen S, Ding K, et al. Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non-small cell lung cancer. J Clin Oncol 2007;25:5240-5247
-
(2007)
J Clin Oncol
, vol.25
, pp. 5240-5247
-
-
Tsao, M.S.1
Aviel-Ronen, S.2
Ding, K.3
-
260
-
-
52049090365
-
Role of k-RAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canadaof Canada Clinical Trials Group study BR.21
-
Zhu CQ, da Cunha Santos G, Ding K, et al. Role of k-RAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canadaof Canada Clinical Trials Group study BR.21. J Clin Oncol 2008;26:4268-4275
-
(2008)
J Clin Oncol
, vol.26
, pp. 4268-4275
-
-
Zhu, C.Q.1
Da Cunha Santos, G.2
Ding, K.3
-
261
-
-
33847416564
-
Class III beta-tubulin espression and benefit from adjuvant cisplatin/vinorelbine chemotheraphy in operable NSCLC: Analysis of NCIC JBR.10
-
Seve P, Lai R, Ding K, et al. Class III beta-tubulin espression and benefit from adjuvant cisplatin/vinorelbine chemotheraphy in operable NSCLC: analysis of NCIC JBR.10. Clin Cancer Res 2007;13:94-99
-
(2007)
Clin Cancer Res
, vol.13
, pp. 94-99
-
-
Seve, P.1
Lai, R.2
Ding, K.3
-
262
-
-
22044445517
-
Erlotinib in previously treated non-small cell lung cancer
-
Sheperd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small cell lung cancer. N Engl J Med 2005;353:123-132
-
(2005)
N Engl J Med
, vol.353
, pp. 123-132
-
-
Sheperd, F.A.1
Rodrigues Pereira, J.2
Ciuleanu, T.3
-
263
-
-
12144285914
-
Ribonucleotide reductase messenger RNA expression and serviva in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients
-
Rosell R, Danenberg KD, Alberola V, et al. Ribonucleotide reductase messenger RNA expression and serviva in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Clin Cancer Res 2004;10:1318-1325
-
(2004)
Clin Cancer Res
, vol.10
, pp. 1318-1325
-
-
Rosell, R.1
Danenberg, K.D.2
Alberola, V.3
-
264
-
-
59449107777
-
Spanish customized adjuvant trial (SCAT) based on BRCA1 mRNA levels
-
abstract 7533
-
Cobo M Sr, Massuti B, Moràn T, et al. Spanish customized adjuvant trial (SCAT) based on BRCA1 mRNA levels. Proc Am Soc Clin Oncol 2008;26(20 Suppl):abstract 7533
-
(2008)
Proc Am Soc Clin Oncol
, vol.26
, Issue.20 SUPPL.
-
-
Cobo Sr., M.1
Massuti, B.2
Moràn, T.3
-
265
-
-
22044453790
-
Erlotinib in lung cancer - molecular and clinical predictors of outcome
-
Tsao MS, Sakurada A, Cutz JC, et al. Erlotinib in lung cancer - molecular and clinical predictors of outcome. N Engl Med 2005;353:133-144
-
(2005)
N Engl Med
, vol.353
, pp. 133-144
-
-
Tsao, M.S.1
Sakurada, A.2
Cutz, J.C.3
|